1 – Late Breaking Abstract|Moderator: Don Dizon, MD, Massachusetts General Hospital/Harvard University, Boston, MA, USA| Volume 145, SUPPLEMENT 1, 219, June 2017

A phase III trial of maintenance therapy in women with advanced ovarian/fallopian tube/peritoneal cancer after a complete clinical response to first-line therapy: An NRG oncology study

      Objective: To compare overall survival (OS) of maintenance chemotherapy (P and PP) to surveillance (S) in women with advanced ovarian/fallopian tube/peritoneal (O/PC/FT) cancer who attained complete clinical response (CCR) following first-line platinum-taxane therapy.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Gynecologic Oncology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect